Editor: M. Iqbal Choudhary

Frontiers in Cardiovascular Drug Discovery

Volume 6

eBook: US $79 Special Offer (PDF + Printed Copy): US $136
Printed Copy: US $96
Library License: US $316
ISSN: 2452-3267 (Print)
ISSN: 1879-6648 (Online)
ISBN: 978-981-5036-91-6 (Print)
ISBN: 978-981-5036-90-9 (Online)
Year of Publication: 2022
DOI: 10.2174/97898150369091220601

Introduction

Frontiers in Cardiovascular Drug Discovery is a book series devoted to publishing the latest advances in cardiovascular drug design and discovery. Each volume brings reviews on the biochemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships of molecules used in cardiovascular therapy. The book series should prove to be of great interest to all medicinal chemists and pharmaceutical scientists involved in preclinical and clinical research in cardiology.

Volume 6 covers the following topics:

-Cardiovascular effects of ranolazine and the scope for translational research: a current review of literature

-Rho/Rho kinase signaling pathway and disease:

-Hibernation or transformation? Challenges in cardiovascular drug development

-New approaches in P2Y12 receptor blocker drugs use

-Pathophysiological links between diabetes and cardiovascular diseases: at the biochemical and molecular levels

Audience

Medicinal chemists and pharmaceutical scientists involved in preclinical and clinical research in cardiology; Clinicians associated with cardiovascular medicine.

Contributors

Editor(s):
M. Iqbal Choudhary
H.E.J. Research Institute of Chemistry
International Center for Chemical and Biological Sciences
University of Karachi, Karachi
Pakistan




Contributor(s):
Ankush Moza
McLaren HealthCare, Premier
Medical Clinics, 1165 South Linden Road Flint
Michigan 48532
USA


Dingguo Zhang
Department of Cardiology
The First Affiliated Hospital of Nanjing Medical University
Nanjing
China


Dolunay Merve Fakioğlu
Department of Biochemistry
Faculty of Pharmacy
Gazi University
Ankara, Turkey


F. Mercanoglu
Department of Cardiology
Istanbul Medical Faculty, Istanbul University
Istanbul
Turkey


G. Mercanoglu
Department of Pharmacology
Hamidiye Faculty of Pharmacy, University of Health Sciences
Istanbul
Turkey


M.M. Towhidul Islam
Department of Biochemistry and Molecular Biology
University of Dhaka
Dhaka-1000
Bangladesh


Mohammad Yousef
McLaren HealthCare
G-3230 Beecher road, Suite 2, Flint
Michigan 48532
USA


Parul Sud
McLaren HealthCare
G-3230 Beecher road, Suite 2, Flint
Michigan 48532
USA


Rebecca Pratiti
McLaren HealthCare
G-3230 Beecher road, Suite 2, Flint
Michigan 48532
USA


Sevgi Akaydin
Department of Biochemistry
Faculty of Pharmacy
Gazi University, Ankara
Turkey


Yearul Kabir
Department of Biochemistry and Molecular Biology
University of Dhaka
Dhaka-1000
Bangladesh


Yiming Wang
Department of Cardiology
Zhenjiang First People’s Hospital
Zhenjiang
China


Yuqing Zhang
Department of Cardiology
The Affiliated Jiangning Hospital of Nanjing Medical University
Nanjing
China